Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 1111 AL 1125

General anesthetics and β-amyloid protein

Xie Z, Xu Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:140-6. doi: 10.1016/j.pnpbp.2012.08.002. Epub 2012 Aug 14.

Mitochondria-associated ER membranes in Alzheimer disease

Schon EA, Area-Gomez E.

Mol Cell Neurosci. 2013 Jul;55:26-36. doi: 10.1016/j.mcn.2012.07.011. Epub 2012 Aug 24.

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, Okello A, Van Laere K, Nelissen N, Vandenbulcke M, Garibotto V, Almkvist O, Kalbe E, Hinz R, Herholz K.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):104-14. doi: 10.1007/s00259-012-2237-2. Epub 2012 Sep 8.

Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study

Sakai M, Hanyu H, Kume K, Sato T, Hirao K, Kanetaka H, Abe S, Kanaya K, Sakurai H, Iwamoto T.

Geriatr Gerontol Int. 2013 Jul;13(3):555-62. doi: 10.1111/j.1447-0594.2012.00934.x. Epub 2012 Sep 10.

Alzheimer disease: a tale of two prions

Nussbaum JM, Seward ME, Bloom GS.

Prion. 2013 Jan-Feb;7(1):14-9. doi: 10.4161/pri.22118. Epub 2012 Sep 10.

Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes

Gibson GE, Hirsch JA, Cirio RT, Jordan BD, Fonzetti P, Elder J.

Mol Cell Neurosci. 2013 Jul;55:17-25. doi: 10.1016/j.mcn.2012.09.001. Epub 2012 Sep 13.

Metal dyshomeostasis and oxidative stress in Alzheimer's disease

Greenough MA, Camakaris J, Bush AI.

Neurochem Int. 2013 Apr;62(5):540-55. doi: 10.1016/j.neuint.2012.08.014. Epub 2012 Sep 8.

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li C, Ebrahimi A, Schluesener H.

Ageing Res Rev. 2013 Jan;12(1):116-40. doi: 10.1016/j.arr.2012.09.002. Epub 2012 Sep 12.

Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis

Maulik M, Westaway D, Jhamandas JH, Kar S.

Mol Neurobiol. 2013 Feb;47(1):37-63. doi: 10.1007/s12035-012-8337-y. Epub 2012 Sep 16.

Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Reddy PH.

Biochim Biophys Acta. 2013 Jan;1832(1):67-75. doi: 10.1016/j.bbadis.2012.09.003. Epub 2012 Sep 17.

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue

Bruggink KA, Jongbloed W, Biemans EA, Veerhuis R, Claassen JA, Kuiperij HB, Verbeek MM.

Anal Biochem. 2013 Feb 15;433(2):112-20. doi: 10.1016/j.ab.2012.09.014. Epub 2012 Sep 26.

Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins

Maatuk N, Samson AO.

Neurotoxicology. 2013 Jan;34:236-42. doi: 10.1016/j.neuro.2012.09.007. Epub 2012 Sep 25.

Self-regulated music stimulation for persons with Alzheimer's disease: impact assessment and social validation

Lancioni GE, Singh NN, O'Reilly MF, Green VA, Ferlisi G, Ferrarese G, Zullo V, Perilli V, Cassano G, Cordiano N, Pinto K, Zonno N.

Dev Neurorehabil. 2013;16(1):17-26. doi: 10.3109/17518423.2012.707693. Epub 2012 Oct 3.

Na⁺-K⁺-ATPase, a potent neuroprotective modulator against Alzheimer disease

Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB.

Fundam Clin Pharmacol. 2013 Feb;27(1):96-103. doi: 10.1111/fcp.12000. Epub 2012 Oct 3.

Axonal transport and mitochondrial dysfunction in Alzheimer's disease

Riemer J, Kins S.

Neurodegener Dis. 2013;12(3):111-24. doi: 10.1159/000342020. Epub 2012 Sep 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias